Ultimovacs
Menu
Close
✕
About
About Ultimovacs
Team
Board of directors
Technology overview
Technology overview
Immunotherapy
Clinical Studies
Phase II studies
Phase I studies
Partnering
Expanded access
Investors
Shares
Financial reports
Presentations and publications
Investor relations contacts
Governance
Analyst coverage
ESG
News
Contact
Ultimovacs
–
News
–
Finansavisen – Topline results
Finansavisen – Topline results
Read the Finansavisen article (in Norwegian)
here